Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.

Oncogene | 2009

ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream targets of ErbB2 should facilitate developing novel therapies for this disease. Gene expression profiling revealed the transcriptional regulator LIM-only protein 4 (LMO4) is upregulated during ErbB2-induced mouse mammary gland tumorigenesis. Although LMO4 is frequently overexpressed in breast cancer and LMO4-overexpressing mice develop mammary epithelial tumors, the mechanisms involved are unknown. In this study, we report that LMO4 is a downstream target of ErbB2 and PI3K in ErbB2-dependent breast cancer cells. Furthermore, LMO4 silencing reduces proliferation of these cells, inducing a G2/M arrest that was associated with decreased cullin-3, an E3-ubiquitin ligase component important for mitosis. Loss of LMO4 subsequently results in reduced Cyclin D1 and Cyclin E. Further supporting a role for LMO4 in modulating proliferation by regulating cullin-3 expression, we found that LMO4 expression oscillates throughout the cell cycle with maximum expression occurring during G2/M and these changes precede oscillations in cullin-3 levels. LMO4 levels are also highest in high-grade/less differentiated breast cancers, which are characteristically highly proliferative. We conclude that LMO4 is a novel cell cycle regulator with a key role in mediating ErbB2-induced proliferation, a hallmark of ErbB2-positive disease.

Pubmed ID: 19648968 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: F31 CA123642
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398-04S1
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398-06A1
  • Agency: NIGMS NIH HHS, United States
    Id: T32-GM007250
  • Agency: NCI NIH HHS, United States
    Id: F31-CA123642
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398
  • Agency: NCI NIH HHS, United States
    Id: P30 CA43703
  • Agency: NCI NIH HHS, United States
    Id: R01-CA090398
  • Agency: NCI NIH HHS, United States
    Id: F31 CA123642-01
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398-05S1
  • Agency: NCI NIH HHS, United States
    Id: P30 CA043703
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398-05
  • Agency: NIAMS NIH HHS, United States
    Id: AR44882
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398-08
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090398-07
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007250
  • Agency: NCI NIH HHS, United States
    Id: F31 CA123642-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MCF-7 (tool)

RRID:CVCL_0031

Cell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SK-BR-3 (tool)

RRID:CVCL_0033

Cell line SK-BR-3 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

BT-474 (tool)

RRID:CVCL_0179

Cell line BT-474 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions